(Q40778582)

23 September 2017

title

Inhibition of the UCI-107 human ovarian carcinoma cell line by a targeted cytotoxic analog of somatostatin, AN-238. (English)

1 reference

23 September 2017

0 references

0 references

1 reference

2

1 reference

23 September 2017

Plonowski A

1

1 reference

23 September 2017

Koppan M

3

1 reference

23 September 2017

Nagy A

4

1 reference

23 September 2017

Arencibia JM

5

1 reference

23 September 2017

Csernus B

6

1 reference

23 September 2017

Halmos G

7

1 reference

23 September 2017

language of work or name

English

0 references

publication date

1 September 2001

1 reference

23 September 2017

number of pages

9

1 reference

based on heuristic

inferred from page(s)

published in

Cancer

1 reference

23 September 2017

volume

92

1 reference

23 September 2017

issue

5

1 reference

23 September 2017

page(s)

1168-1176

1 reference

23 September 2017

cites work

Cancer statistics, 1999.

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010901%2992%3A5%3C1168%3A%3AAID-CNCR1435%3E3.0.CO%3B2-6

Cancer chemotherapy based on targeting of cytotoxic peptide conjugates to their receptors on tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010901%2992%3A5%3C1168%3A%3AAID-CNCR1435%3E3.0.CO%3B2-6

Somatostatin receptor scintigraphy with [111In-DTPA-D-Phe1]- and [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010901%2992%3A5%3C1168%3A%3AAID-CNCR1435%3E3.0.CO%3B2-6

Therapy of neuroendocrine tumors with radiolabeled MIBG and somatostatin analogues

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010901%2992%3A5%3C1168%3A%3AAID-CNCR1435%3E3.0.CO%3B2-6

In vitro detection of somatostatin receptors in human tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010901%2992%3A5%3C1168%3A%3AAID-CNCR1435%3E3.0.CO%3B2-6

Evaluation of receptors for somatostatin in various tumors using different analogs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010901%2992%3A5%3C1168%3A%3AAID-CNCR1435%3E3.0.CO%3B2-6

Synthesis and biological evaluation of cytotoxic analogs of somatostatin containing doxorubicin or its intensely potent derivative, 2-pyrrolinodoxorubicin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010901%2992%3A5%3C1168%3A%3AAID-CNCR1435%3E3.0.CO%3B2-6

Characterization and development of UCI 107, a primary human ovarian carcinoma cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010901%2992%3A5%3C1168%3A%3AAID-CNCR1435%3E3.0.CO%3B2-6

Stability of cytotoxic luteinizing hormone-releasing hormone conjugate (AN-152) containing doxorubicin 14-O-hemiglutarate in mouse and human serum in vitro: implications for the design of preclinical studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010901%2992%3A5%3C1168%3A%3AAID-CNCR1435%3E3.0.CO%3B2-6

Synthesis and biological activity of highly potent octapeptide analogs of somatostatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010901%2992%3A5%3C1168%3A%3AAID-CNCR1435%3E3.0.CO%3B2-6

High yield conversion of doxorubicin to 2-pyrrolinodoxorubicin, an analog 500-1000 times more potent: structure-activity relationship of daunosamine-modified derivatives of doxorubicin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010901%2992%3A5%3C1168%3A%3AAID-CNCR1435%3E3.0.CO%3B2-6

In vitro targeting of a cytotoxic analog of luteinizing hormone-releasing hormone AN-207 to ES-2 human ovarian cancer cells as demonstrated by microsatellite analyses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010901%2992%3A5%3C1168%3A%3AAID-CNCR1435%3E3.0.CO%3B2-6

Regulation of insulin-like growth factor-binding protein-1 and progesterone secretion from human granulosa-luteal cells: effects of octreotide and insulin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010901%2992%3A5%3C1168%3A%3AAID-CNCR1435%3E3.0.CO%3B2-6

Cloning, expression, pharmacology and tissue distribution of the mouse somatostatin receptor subtype 5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010901%2992%3A5%3C1168%3A%3AAID-CNCR1435%3E3.0.CO%3B2-6

Interspecies differences in enzymes reacting with organophosphates and their inhibition by paraoxon in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010901%2992%3A5%3C1168%3A%3AAID-CNCR1435%3E3.0.CO%3B2-6

Peptide analogs in the therapy of prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010901%2992%3A5%3C1168%3A%3AAID-CNCR1435%3E3.0.CO%3B2-6

Intraperitoneal radioimmunotherapy of ovarian cancer with 177Lu-CC49: a phase I/II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010901%2992%3A5%3C1168%3A%3AAID-CNCR1435%3E3.0.CO%3B2-6

The use of luteinizing hormone releasing hormone agonists and antagonists in gynaecological cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010901%2992%3A5%3C1168%3A%3AAID-CNCR1435%3E3.0.CO%3B2-6

Growth inhibition of human ovarian cancers by cytotoxic analogues of luteinizing hormone-releasing hormone

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010901%2992%3A5%3C1168%3A%3AAID-CNCR1435%3E3.0.CO%3B2-6

Targeted cytotoxic analog of luteinizing hormone-releasing hormone AN-207 inhibits growth of OV-1063 human epithelial ovarian cancers in nude mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010901%2992%3A5%3C1168%3A%3AAID-CNCR1435%3E3.0.CO%3B2-6

Yttrium-90-labelled somatostatin-analogue for cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010901%2992%3A5%3C1168%3A%3AAID-CNCR1435%3E3.0.CO%3B2-6

Inhibition of growth of MX-1, MCF-7-MIII and MDA-MB-231 human breast cancer xenografts after administration of a targeted cytotoxic analog of somatostatin, AN-238

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010901%2992%3A5%3C1168%3A%3AAID-CNCR1435%3E3.0.CO%3B2-6

A targeted cytotoxic somatostatin (SST) analogue, AN-238, inhibits the growth of H-69 small-cell lung carcinoma (SCLC) and H-157 non-SCLC in nude mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010901%2992%3A5%3C1168%3A%3AAID-CNCR1435%3E3.0.CO%3B2-6

The somatostatin analogue, octreotide, modifies both steroidogenesis and IGFBP-1 secretion in human luteinizing granulosa cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010901%2992%3A5%3C1168%3A%3AAID-CNCR1435%3E3.0.CO%3B2-6

In vivo inhibition of PC-3 human androgen-independent prostate cancer by a targeted cytotoxic bombesin analogue, AN-215

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010901%2992%3A5%3C1168%3A%3AAID-CNCR1435%3E3.0.CO%3B2-6

10.1002/1097-0142(20010901)92:5<1168::AID-CNCR1435>3.0.CO;2-6

21 January 2018

Identifiers

DOI

1 reference

23 September 2017

1 reference